Get the Stockscreener App
18.97
0.05%
0.010
After Hours:
18.97
Zimvie Inc stock is traded at $18.97, with a volume of 275.86K.
It is up +0.05% in the last 24 hours and up +0.53% over the past month.
ZimVie Inc is focused on the dental and spine markets and their respective growth drivers such as implants, surgical tools, bone graft substitutes, spinal fusion implants, non-fusion alternatives, and digital care management solutions. Business is organized into two operating segments the spine products segment and the dental products segment.
See More
Previous Close:
$18.96
Open:
$18.96
24h Volume:
275.86K
Relative Volume:
0.42
Market Cap:
$535.16M
Revenue:
$242.12M
Net Income/Loss:
$-351.72M
P/E Ratio:
-1.4274
EPS:
-13.29
Net Cash Flow:
$24.82M
1W Performance:
+0.29%
1M Performance:
+0.53%
6M Performance:
+107.32%
1Y Performance:
+18.56%
1-Day Range:
$18.96
$18.99
1-Week Range:
$18.91
$18.99
52-Week Range:
$8.15
$19.01
Zimvie Inc Stock (ZIMV) Company Profile
Name
Zimvie Inc
Sector
Industry
Phone
800-342-5454
Address
4555 RIVERSIDE DRIVE, PALM BEACH GARDEN
Compare ZIMV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ZIMV
Zimvie Inc
|
18.97 | 534.88M | 242.12M | -351.72M | 24.82M | -13.29 |
|
ABT
Abbott Laboratories
|
131.38 | 230.73B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
94.95 | 141.37B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
364.92 | 139.39B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.58 | 122.43B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
72.95 | 43.41B | 5.69B | 1.41B | 577.90M | 6.9828 |
Zimvie Inc Stock (ZIMV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-31-25 | Downgrade | B. Riley Securities | Buy → Neutral |
| Jul-22-25 | Upgrade | Barclays | Underweight → Equal Weight |
| Apr-10-25 | Initiated | B. Riley Securities | Buy |
| Mar-13-25 | Downgrade | Needham | Buy → Hold |
| May-16-24 | Upgrade | Needham | Hold → Buy |
| Nov-16-23 | Initiated | Needham | Hold |
| Dec-21-22 | Initiated | Barclays | Underweight |
| Jun-17-22 | Initiated | JP Morgan | Neutral |
| Mar-18-22 | Initiated | Guggenheim | Neutral |
View All
Zimvie Inc Stock (ZIMV) Latest News
Is ZimVie Inc. (O23) stock undervalued historicallyQuarterly Trade Report & Step-by-Step Swing Trade Plans - newser.com
Is a relief rally coming for ZimVie Inc. holdersEarnings Overview Report & Weekly Watchlist of Top Performers - newser.com
ZimVie Inc. stock trendline breakdownWeekly Trade Summary & AI Enhanced Market Trend Forecasts - newser.com
How risky is ZimVie Inc. stock nowJuly 2025 Closing Moves & Technical Analysis for Trade Confirmation - newser.com
Combining price and volume data for ZimVie Inc.Take Profit & Real-Time Chart Breakout Alerts - newser.com
Is ZimVie Inc. stock reversal real or fakeMarket Sentiment Report & Community Verified Trade Alerts - newser.com
Will ZimVie Inc. stock recover after recent drop2025 Top Decliners & Safe Capital Growth Tips - newser.com
Risk adjusted return profile for ZimVie Inc. analyzedWeekly Trade Recap & Verified Technical Trade Signals - newser.com
Automated trading signals detected on ZimVie Inc.July 2025 Setups & High Accuracy Investment Signals - newser.com
ZimVie stockholders approve acquisition by ARCHIMED affiliate - Investing.com Nigeria
ZimVie Inc Stockholders Approve Acquisition by ARCHIMED - TipRanks
Why ZimVie Inc. (O23) stock attracts wealthy investorsEarnings Risk Summary & Short-Term Trading Alerts - newser.com
Is ZimVie Inc. (O23) stock attractive for dividend growthJuly 2025 Movers & Safe Capital Growth Tips - newser.com
ZimVie shareholders approve acquisitiion by ARCHIMED - TipRanks
ZimVie Stockholders Vote to Approve Acquisition by ARCHIMED - The Manila Times
ZimVie Stockholders Approve Merger with ARCHIMED Affiliate, Closing Expected on October 20, 2025 - Quiver Quantitative
ZimVie stockholders vote to approve acquisition by Archimed - MarketScreener
What momentum shifts mean for ZimVie Inc.2025 Geopolitical Influence & Growth Focused Entry Reports - newser.com
InvestingPro Fair Value model captures 77% gain in ZimVie before buyout By Investing.com - Investing.com UK
How to use Fibonacci retracement on ZimVie Inc.July 2025 Snapshot & Stock Portfolio Risk Control - newser.com
Visual analytics tools that track ZimVie Inc. performanceEarnings Trend Report & Verified Entry Point Signals - newser.com
ZimVie (NASDAQ:ZIMV) Receives "Sell (D-)" Rating from Weiss Ratings - MarketBeat
ZimVie to be acquired by Archimed for $19.00 per share in cash - MSN
Will ZimVie Inc. (O23) stock outperform energy sector in 2025Gap Down & Stock Timing and Entry Methods - newser.com
How to read the order book for ZimVie Inc.Weekly Trade Analysis & High Accuracy Swing Entry Alerts - newser.com
How strong is ZimVie Inc. (O23) stock earnings growthWeekly Market Report & Comprehensive Market Scan Reports - newser.com
Will ZimVie Inc. (O23) stock extend growth storyJuly 2025 Trends & Long-Term Capital Growth Strategies - newser.com
Will ZimVie Inc. stock benefit from commodity prices2025 Price Action Summary & Detailed Earnings Play Alerts - newser.com
What to expect from ZimVie Inc. in the next 30 days2025 AllTime Highs & Verified Short-Term Plans - newser.com
Visualizing ZimVie Inc. stock with heatmapsQuarterly Earnings Summary & Long-Term Safe Investment Ideas - newser.com
Chart based exit strategy for ZimVie Inc.July 2025 Patterns & Fast Gain Stock Trading Tips - newser.com
ZimVie Inc Faces Legal Challenges Over Merger - The Globe and Mail
What analysts say about ZimVie Inc stockValue Stock Picks & Rapid Wealth Building Tips - earlytimes.in
Short Interest in ZimVie Inc. (NASDAQ:ZIMV) Declines By 42.7% - MarketBeat
ZimVie Inc. (NASDAQ:ZIMV) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Is ZimVie Inc. forming a bottoming baseTrade Exit Summary & Technical Pattern Based Buy Signals - newser.com
Zimvie Inc Stock (ZIMV) Financials Data
Revenue
Net Income
Cash Flow
EPS
Zimvie Inc Stock (ZIMV) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Kidwell Heather | See remarks below. |
May 15 '25 |
Option Exercise |
0.00 |
8,063 |
0 |
85,880 |
| Kanaglekar Indraneel | See remarks below. |
May 15 '25 |
Option Exercise |
0.00 |
10,966 |
0 |
64,830 |
| Jamali Vafa | See remarks below. |
May 15 '25 |
Option Exercise |
0.00 |
48,379 |
0 |
408,636 |
| Heppenstall Richard | See remarks below. |
May 15 '25 |
Option Exercise |
0.00 |
16,127 |
0 |
130,373 |
| Jamali Vafa | See remarks below. |
Apr 01 '25 |
Option Exercise |
0.00 |
21,331 |
0 |
369,590 |
| Schneider Sandra | Chief Accounting Officer |
Mar 10 '25 |
Option Exercise |
0.00 |
3,590 |
0 |
33,252 |
| Schneider Sandra | Chief Accounting Officer |
Mar 07 '25 |
Option Exercise |
0.00 |
6,542 |
0 |
31,415 |
| Heppenstall Richard | See remarks below. |
Mar 10 '25 |
Option Exercise |
0.00 |
6,938 |
0 |
115,936 |
| Heppenstall Richard | See remarks below. |
Mar 07 '25 |
Option Exercise |
0.00 |
24,650 |
0 |
115,337 |
| Kanaglekar Indraneel | See remarks below. |
Mar 10 '25 |
Option Exercise |
0.00 |
4,163 |
0 |
54,878 |
0.01%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):